We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.
MBII

Delisted

MBII was delisted on the 12th of July, 2022.

Back to rankings

44 hedge funds and large institutions have $66.5M invested in Marrone Bio Innovations, Inc. in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

2% less funds holding

Funds holding: 45 → 44 (-1)

18% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 11

19% less capital invested

Capital invested by funds: $82.4M → $66.5M (-$15.9M)

Holders
44
Holders Change
-1
Holders Change %
-2.22%
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
9
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FC
Fairpointe Capital
Illinois
+$203K
2
SIM
Spark Investment Management
New York
+$98.7K
3
PP
Paloma Partners
Connecticut
+$75.8K
4
OAM
Oxford Asset Management
United Kingdom
+$69.8K
5
State Street
State Street
Massachusetts
+$50.4K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$120K
2
Deutsche Bank
Deutsche Bank
Germany
-$80.2K
3
PPA
Parametric Portfolio Associates
Washington
-$74K
4
Jane Street
Jane Street
New York
-$64K
5
Barclays
Barclays
United Kingdom
-$37K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Board of Administration of Florida Retirement System
26
State Board of Administration of Florida Retirement System
Florida
$47K – – –
UBS Group
27
UBS Group
Switzerland
$42K +$23.6K +15,419 +117%
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$31K – – –
Invesco
29
Invesco
Georgia
$28K -$27.3K -17,798 -48%
WIC
30
Whitegate Investment Counselors
New Hampshire
$22K – – –
Citigroup
31
Citigroup
New York
$21K -$982 -641 -4%
JP Morgan Chase
32
JP Morgan Chase
New York
$20K +$1.99K +1,298 +10%
TRCT
33
Tower Research Capital (TRC)
New York
$18K -$15.9K -10,382 -46%
Citadel Advisors
34
Citadel Advisors
Florida
$16K -$26.2K -17,096 -61%
AF
35
Allworth Financial
California
$16K – – –
RJFSA
36
Raymond James Financial Services Advisors
Florida
$16K – – –
Legal & General Group
37
Legal & General Group
United Kingdom
$12K – – –
AIP
38
Ameritas Investment Partners
Nebraska
$7K – – –
AG
39
Advisor Group
Arizona
$6K +$6.13K +4,000 New
CFA
40
Carroll Financial Associates
North Carolina
$3K – – –
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$1.42K -$1.26K -820 -46%
LTFS
42
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
$1K +$602 +393 +104%
FDCDDQ
44
Federation des caisses Desjardins du Quebec
Quebec, Canada
$735 – – –
Goldman Sachs
45
Goldman Sachs
New York
– -$120K -65,818 Closed
PPA
46
Parametric Portfolio Associates
Washington
– -$74K -40,303 Closed
Jane Street
47
Jane Street
New York
– -$64K -34,705 Closed
Barclays
48
Barclays
United Kingdom
– -$37K -20,451 Closed
SG Americas Securities
49
SG Americas Securities
New York
– -$32K -17,491 Closed
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
– -$3K -1,735 Closed
1
2

MBII Hedge Fund Activity: Q4 2018 in Review

44 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q4 2018, worth a combined $66.5M — down 19% from $82.4M a quarter earlier.

Fund positioning in MBII was balanced in Q4 2018: 6 funds opened new positions, 6 closed out, 9 added to existing stakes and 11 trimmed.

The largest buyer was Fairpointe Capital, opening a new position worth an estimated $203K. The largest seller was Goldman Sachs, exiting entirely with an estimated $120K sold.

  • 44 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q4 2018, down from 45 in Q3 2018.
  • Funds reported $66.5M of Marrone Bio Innovations, Inc. stock for Q4 2018, down 19% quarter-over-quarter.
  • 6 funds opened new Marrone Bio Innovations, Inc. positions in Q4 2018 and 6 closed out, a net change of 0 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q4 2018 was Fairpointe Capital, an estimated $203K added.
  • The largest Marrone Bio Innovations, Inc. seller in Q4 2018 was Goldman Sachs, an estimated $120K sold.

Based on aggregated 13F filings for Q4 2018.